Hey Dave,
The movement into a CHO cell line is definitely not negative news by any means. On the contrary, it is normal to research a drug in a cell line that is high expressing before moving expression into a more suitable cell line such as CHO for large-scale production.
this news is mildly interesting. I don't hold. yet.
All IMO, dyor.
Ann: Patrys Reports Progress on Preclinical Programmes, page-43
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.172M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $3.633K | 1.210M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 29971474 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 6323414 | 8 |
View Market Depth
| Last trade - 15.58pm 27/01/2025 (20 minute delay) ? |
| PAB (ASX) Chart |